IMC Change in substantial holding 30/04/24 download Created with Sketch. 643.75KB Share IMC Immuron CEO Steven Lydeamore to present at The Watchlist 23/04/24 download Created with Sketch. 1.83MB Share IMC Immuron to host Live Virtual Event 15/04/24 download Created with Sketch. 296.16KB Share IMC Immuron Travelan sales continued strong growth 10/04/24 PRICE SENSITIVE download Created with Sketch. 315.78KB Share IMC Change in substantial holding 22/03/24 download Created with Sketch. 1.51MB Share IMC Notice under section 708A 14/03/24 download Created with Sketch. 179.38KB Share IMC Change of Director's Interest Notice (DP) 14/03/24 download Created with Sketch. 168.99KB Share IMC Application for quotation of securities - IMC 14/03/24 download Created with Sketch. 16.05KB Share IMC Immuron CEO, Steven Lydeamore to present at Coffee Microcaps 14/03/24 download Created with Sketch. 1.29MB Share IMC Change in substantial holding 14/03/24 download Created with Sketch. 1.49MB Share IMC Travelan to progress to Phase 3 Clinical Trials in the US 07/03/24 PRICE SENSITIVE download Created with Sketch. 408.71KB Share IMC Trading Halt 05/03/24 PRICE SENSITIVE download Created with Sketch. 221.96KB Share IMC Change in substantial holding 01/03/24 download Created with Sketch. 1.52MB Share IMC Appendix 4D and Half Year Report 28/02/24 PRICE SENSITIVE download Created with Sketch. 2.93MB Share IMC Presentation to Australian Biologics Festival 2024 21/02/24 download Created with Sketch. 2.48MB Share IMC Immuron achieves record Travelan sales 13/02/24 PRICE SENSITIVE download Created with Sketch. 260.27KB Share IMC Investor Webinar Presentation 08/02/24 download Created with Sketch. 1.26MB Share IMC Immuron achieves record half yearly Travelan sales 16/01/24 PRICE SENSITIVE download Created with Sketch. 277.27KB Share IMC Immuron Clinical Trials Update 22/12/23 download Created with Sketch. 292.74KB Share IMC First Patients Enrolled in Campylobacter Clinical Study 04/12/23 PRICE SENSITIVE download Created with Sketch. 303.92KB Share IMC Investor Webinar Presentation 28/11/23 download Created with Sketch. 1.51MB Share IMC Change of Director's Interest Notice (PB) 24/11/23 download Created with Sketch. 170.32KB Share IMC Notification regarding unquoted securities - IMC 24/11/23 download Created with Sketch. 25.45KB Share IMC Amended Constitution 22/11/23 download Created with Sketch. 463.37KB Share IMC Results of Annual General Meeting 21/11/23 download Created with Sketch. 134.97KB Share IMC Presentation to Annual General Meeting 21/11/23 download Created with Sketch. 774.11KB Share IMC Investor Webinar Presentation 13/11/23 download Created with Sketch. 1.66MB Share IMC Immuron CEO, Steven Lydeamore to present at AusBioInvest 30/10/23 download Created with Sketch. 1.36MB Share IMC Notice of Annual General Meeting/Proxy Form 23/10/23 download Created with Sketch. 424.96KB Share IMC Travelan Clinical Study Cohort 2 commences 18/10/23 download Created with Sketch. 303.18KB Share IMC Immuron achieves record quarterly Travelan sales 11/10/23 PRICE SENSITIVE download Created with Sketch. 279.1KB Share IMC Immuron CEO, Steven Lydeamore to present at LD Micro 04/10/23 download Created with Sketch. 1.46MB Share IMC Appendix 4G 28/09/23 download Created with Sketch. 263.25KB Share IMC Corporate Governance Statement 28/09/23 download Created with Sketch. 199.71KB Share IMC Annual Report to shareholders 28/09/23 download Created with Sketch. 4.04MB Share IMC Immuron achieves record monthly Travelan sales 13/09/23 PRICE SENSITIVE download Created with Sketch. 262.36KB Share IMC Immuron CEO, Steven Lydeamore to present at H.C. Wainwright 11/09/23 download Created with Sketch. 1.63MB Share IMC Appendix 4E Preliminary Final Report 30/08/23 PRICE SENSITIVE download Created with Sketch. 2.14MB Share IMC Immuron present to Military Health System Research Symposium 14/08/23 download Created with Sketch. 453.76KB Share IMC Immuron Receives TGA GMP Clearance 09/08/23 PRICE SENSITIVE download Created with Sketch. 277.95KB Share IMC Immuron enrols patients in Travelan clinical study 25/07/23 PRICE SENSITIVE download Created with Sketch. 303.58KB Share IMC Immuron CEO, Steven Lydeamore to present at Bioshares 24/07/23 download Created with Sketch. 1.65MB Share IMC Notification regarding unquoted securities - IMC 12/07/23 download Created with Sketch. 27.28KB Share IMC Letter to Shareholders 11/07/23 download Created with Sketch. 285.32KB Share IMC Immuron FY23 Sales increase 136% on FY22 Sales 05/07/23 PRICE SENSITIVE download Created with Sketch. 280.73KB Share IMC Immuron Chairman Transition 30/06/23 download Created with Sketch. 255.93KB Share IMC Letter to Shareholders 22/06/23 download Created with Sketch. 417.25KB Share IMC Immuron CEO, Steven Lydeamore presents at LD Micro 07/06/23 download Created with Sketch. 1.8MB Share IMC Immuron Initiates Recruitment of Travelan Clinical Study 30/05/23 PRICE SENSITIVE download Created with Sketch. 297.14KB Share IMC FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic 08/05/23 PRICE SENSITIVE download Created with Sketch. 295.07KB Share IMC IMC CEO Steven Lydeamore to present at Coffee Microcaps 02/05/23 download Created with Sketch. 998.52KB Share IMC Q3 FY23 Business Update Presentation 19/04/23 PRICE SENSITIVE download Created with Sketch. 866.7KB Share IMC Q3 FY23 Business Update Webinar 11/04/23 download Created with Sketch. 285.87KB Share IMC Immuron Q3 Sales reach 150% of 1H Sales 06/04/23 PRICE SENSITIVE download Created with Sketch. 262.26KB Share IMC Notification of cessation of securities - IMC 16/03/23 download Created with Sketch. 21.57KB Share IMC Appendix 4D and Half Year Report 28/02/23 PRICE SENSITIVE download Created with Sketch. 2.8MB Share IMC Business Update Presentation 28/02/23 PRICE SENSITIVE download Created with Sketch. 746.36KB Share IMC Immuron CEO Steven Lydeamore to host investor webinar 15/02/23 download Created with Sketch. 211.84KB Share IMC Immuron and US NMRC respond to CampETEC FDA Clinical Hold 25/01/23 download Created with Sketch. 252.86KB Share IMC US DOD Travelan Clinical Recruitment Milestone 18/01/23 download Created with Sketch. 285.22KB Share IMC Immuron Receives European Patent on Drug Composition 17/01/23 download Created with Sketch. 352.58KB Share IMC Change in substantial holding 30/12/22 download Created with Sketch. 1.57MB Share IMC Immuron Receives FDA Approval for Travelan IND Application 23/12/22 PRICE SENSITIVE download Created with Sketch. 285.59KB Share IMC Immuron Submits IND Application To FDA for Travelan 05/12/22 download Created with Sketch. 282.81KB Share IMC Amended Constitution 01/12/22 download Created with Sketch. 496.22KB Share IMC Results of Annual General Meeting 21/11/22 download Created with Sketch. 161.19KB Share IMC AGM Presentation 21/11/22 download Created with Sketch. 534.76KB Share IMC Immuron completes strategic investment in Ateria Health 16/11/22 PRICE SENSITIVE download Created with Sketch. 323.13KB Share IMC Immuron CEO Steven Lydeamore to present at AusBioInvest 26/10/22 download Created with Sketch. 645.88KB Share IMC Notice of Annual General Meeting/Proxy Form 21/10/22 download Created with Sketch. 478.06KB Share IMC IMC investment in leading gut health biotech Ateria Health 13/10/22 PRICE SENSITIVE download Created with Sketch. 343.35KB Share IMC Immuron Executes Travelan Clinical Trial Agreement Pharmaron 04/10/22 download Created with Sketch. 284.86KB Share IMC Appendix 4G 09/09/22 download Created with Sketch. 323.73KB Share IMC Corporate Governance Statement 09/09/22 download Created with Sketch. 201.39KB Share IMC Annual Report to shareholders 09/09/22 download Created with Sketch. 3.86MB Share IMC FY22 Results and Business Update Presentation 31/08/22 download Created with Sketch. 881.7KB Share IMC Appendix 4E and Preliminary Final Report 31/08/22 PRICE SENSITIVE download Created with Sketch. 1.46MB Share IMC Immuron CEO, Steven Lydeamore, to host an investor webinar 29/08/22 download Created with Sketch. 281.17KB Share IMC Immuron Update on IMM-124E SARS-CoV-2 Research 19/08/22 PRICE SENSITIVE download Created with Sketch. 284.76KB Share IMC Update on IND Application for Campylobacter ETEC Therapeutic 26/07/22 download Created with Sketch. 285.31KB Share IMC North American Travelan Sales up 494%, Global sales up 431% 11/07/22 PRICE SENSITIVE download Created with Sketch. 258.28KB Share IMC European Patent Notification on Drug Composition for CDI 07/07/22 PRICE SENSITIVE download Created with Sketch. 388.35KB Share IMC Change of Director's Interest Notice (DP) 04/07/22 download Created with Sketch. 182.63KB Share IMC Notification regarding unquoted securities - IMC 01/07/22 download Created with Sketch. 25.37KB Share IMC Change of Director's Interest Notice 15/06/22 download Created with Sketch. 191.78KB Share IMC Notification of cessation of securities - IMC 14/06/22 download Created with Sketch. 21.61KB Share IMC Notification of cessation of securities - IMC 10/06/22 download Created with Sketch. 22.1KB Share IMC Change in substantial holding 25/05/22 download Created with Sketch. 889.62KB Share IMC US DoD NMRC files IND application with FDA 11/05/22 PRICE SENSITIVE download Created with Sketch. 315.64KB Share IMC US DoD Uniformed Services University Clinical Update 09/05/22 PRICE SENSITIVE download Created with Sketch. 301.1KB Share IMC Appointment of Mr Steven Lydeamore as Chef Executive Officer 05/05/22 PRICE SENSITIVE download Created with Sketch. 292.96KB Share IMC Immuron Q3 Global Sales up 216% YoY 27/04/22 PRICE SENSITIVE download Created with Sketch. 267.71KB Share IMC Immuron new MTEC project proposal 19/04/22 download Created with Sketch. 344.8KB Share IMC Initial Director's Interest Notice 16/03/22 download Created with Sketch. 226.66KB Share IMC Appointment of Paul Brennan as Non-Executive Director 16/03/22 download Created with Sketch. 251.13KB Share IMC Half Yearly Report and Accounts 25/02/22 PRICE SENSITIVE download Created with Sketch. 3.23MB Share IMC Response to ASX Query 24/01/22 PRICE SENSITIVE download Created with Sketch. 315.93KB Share IMC Change in substantial holding 24/01/22 download Created with Sketch. 854.54KB Share IMC Immuron Receives AUD $306,154 R&D Tax Concession Refund 17/01/22 download Created with Sketch. 224.4KB Share IMC Immuron Receives European Patent on Drug to Treat Diarrhea 13/01/22 PRICE SENSITIVE download Created with Sketch. 301.66KB Share